Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis | Journal Scan

Study Questions:

What is the efficacy and safety profile of a factor XI antisense oligonucleotide (FXI-ASO) as compared to enoxaparin for the prevention of venous thromboembolism (VTE) in patients undergoing total knee arthroplasty?